Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Google Scholar citation report
Citations : 2305

Journal of Obesity & Weight Loss Therapy received 2305 citations as per Google Scholar report

Journal of Obesity & Weight Loss Therapy peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Open J Gate
  • Genamics JournalSeek
  • Centre for Agriculture and Biosciences International (CABI)
  • RefSeek
  • Hamdard University
  • EBSCO A-Z
  • OCLC- WorldCat
  • SWB online catalog
  • CABI full text
  • Cab direct
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
  • University of Bristol
  • Pubmed
  • ICMJE
Share This Page

Metformin as treatment in for obese and sever obese adult with family history of diabetes

4th International Conference and Exhibition on Obesity and Weight Management

Javad Arian Nezhad1 and Sanaz karimi2

1 javad, ARIAN POOYA obesity research center, Iran 2Pharmacist, member of ARIAN POOYA obesity researc3.h center, Iran

ScientificTracks Abstracts: J Obes Weight Loss Ther

DOI: 10.4172/2165-7904.C1.024

Abstract
Introduction: There was some evidence that Metformin used in aid of weight loss in obese patients or in Polycystic Ovary Syndrome is beneficial. (2003) we wanted to determine whether Metformin was an effective medication for treatment of obese and sever obese adults who have family history of diabetes mellitus. Methods: In this study we had 1457 patients .we divided them into two groups with family history of diabetes and with no history of diabetes all of them were women between 25-45 years the patients with history of diabetes were prescribed to take two tablets of Metformin 500 mg per day. They were then followed up four weeks for assessment. Also we divided them into three groups of BMI. (Over weight, obese,sever obese) Results: we compared average weight at start with average weight at the end among these three groups; we noted that there are not differences between them in different stage of Obesity. Conclusion: We suggest that Metformin can not improve losing weight between patients with family history of type 2 Diabetes. Keywords: Metformin, family history, diabetes
Biography

Email: behroozms@yahoo.com

Relevant Topics
Top